Miraca Life Sciences to Highlight Ethnicity Trends in Pathology Diagnoses with Research Presentations at Digestive Disease Week, 2014

Of 11 research presentations Miraca will present at DDW, seven examine the role of ethnicity in pathology diagnosis, and two were honored for Platform Presentation.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
“The inclusion of ethnicity in some of our analyses provides an unprecedented opportunity for Miraca’s GI pathologists to discover trends that could ultimately impact treatment and medical outcomes,” said Richard Lash, MD.

Irving, Texas (PRWEB) April 24, 2014

Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, will highlight ethnicity trends in pathology diagnoses in its presentation of research at Digestive Disease Week (DDW) 2014, considered the largest and most prestigious meeting in the world for GI professionals. DDW will be held May 3-6 in Chicago at McCormick Place. Of the 11 combined research presentations Miraca will present at DDW, seven examine the role of ethnicity in pathology diagnosis, and two were honored for Platform Presentation.

New sophisticated methods to determine patients’ ethnicity are enabling Miraca’s pathologists to investigate interesting associations. “The inclusion of ethnicity in some of our analyses provides an unprecedented opportunity for Miraca’s GI pathologists to discover trends that could ultimately impact treatment and medical outcomes,” said Richard Lash, MD, Chief Medical Officer for Miraca Life Sciences.

At DDW this year, Miraca will present the following studies that examine ethnicity trends:

  • Ethnic Distribution of Atrophic Autoimmune Gastritis in the United States (honored to be presented as a Platform Presentation)
  • Influence of Patients’ Ethnicity on the Gastric Biopsy Sampling Practices
  • High Prevalence of Ulcerative Colitis in U.S. Residents of Indian Origin
  • The Prevalence of Gastric Preneoplastic Lesions in East Asians and Hispanics in the United States Parallels the Incidence of Gastric Cancer in the Ancestral Countries
  • Low Prevalence of Microscopic Colitis and Inflammatory Bowel in Americans of East Asian Ancestry
  • Barrett’s Esophagus is Not Rare in Asian Patients Who Have Esophageal Biopsies Taken in the United States
  • Low Prevalence of Eosinophilic Esophagitis in Hispanics and Asians in the United States

One of the above Miraca studies, Low Prevalence of Microscopic Colitis and Inflammatory Bowel in Americans of East Asian Ancestry, has been selected by the DDW Program Chairs to be featured in a special poster hall tour session, which will involve a private mini-presentation to a moderated tour group.

Additionally, Miraca will present the following research highlighting additional topics in gastrointestinal pathology:

  • Gastric Antral Vascular Ectasia: The Invaluable Role of the Gastric Biopsy in Detection and Confirmation (honored to be presented as a Platform Presentation)
  • Atrophic Autoimmune Gastritis: Manifestations and Clinicopathologic Associations in a Large United States Cohort
  • The Yield of Colonic Biopsy in the Evaluation of Chronic Unexplained Diarrhea
  • Granulomas In Crohn’s Disease Are Associated With More Severe Disease Expression

Research presentations are part of Miraca’s ongoing effort to provide physicians with high-quality information at the investigative and applied practice level to reinforce and update their knowledge of pathology in their unique areas of interest. Miraca enhances its pathologists’ laboratory and clinical acumen through the publication of groundbreaking information in high-impact peer-reviewed journals, global symposia, workshops, seminars and courses nationwide.

Dr. Lash continued: “Miraca Life Sciences is dedicated to ensuring that every patient receives the right answer, and this mission is the driver of our innovation as we aim to expand pathology’s boundaries through the ideas and discoveries of our pathologist-scientists.”

About Miraca Life Sciences
Miraca Life Sciences specializes in the development and commercialization of the highest quality academic pathology services, primarily in the fields of dermatology, hematology, gastroenterology and urology. The company’s core team of more than 90 academic-caliber specialists utilizes state-of-the-art pathology laboratories currently headquartered in Irving, Texas, and throughout the United States to serve more than 5,500 patients every day. Through rigorous quality assurance, daily and monthly conferences, and close relationships with clinical partners, Miraca Life Sciences continuously improves diagnostic precision.

About DDW
Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 3-6, 2014, at McCormick Place in Chicago. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at http://www.ddw.org.
# # #


Contact